Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 249 JPY 5.76% Market Closed
Market Cap: 30.9B JPY

Fuji Pharma Co Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fuji Pharma Co Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Tax Provision
-ÂĄ1.4B
CAGR 3-Years
-18%
CAGR 5-Years
-9%
CAGR 10-Years
-2%
Takeda Pharmaceutical Co Ltd
TSE:4502
Tax Provision
-ÂĄ26.6B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Tax Provision
-ÂĄ66.9B
CAGR 3-Years
-124%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Otsuka Holdings Co Ltd
TSE:4578
Tax Provision
ÂĄ11.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chugai Pharmaceutical Co Ltd
TSE:4519
Tax Provision
-ÂĄ155.7B
CAGR 3-Years
-10%
CAGR 5-Years
-25%
CAGR 10-Years
-21%
Astellas Pharma Inc
TSE:4503
Tax Provision
ÂĄ20.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Fuji Pharma Co Ltd
Glance View

Market Cap
30.5B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
2 107.81 JPY
Undervaluation 41%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Tax Provision?
Tax Provision
-1.4B JPY

Based on the financial report for Dec 31, 2024, Fuji Pharma Co Ltd's Tax Provision amounts to -1.4B JPY.

What is Fuji Pharma Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-2%

Over the last year, the Tax Provision growth was 14%. The average annual Tax Provision growth rates for Fuji Pharma Co Ltd have been -18% over the past three years , -9% over the past five years , and -2% over the past ten years .

Back to Top